Small hairpin RNA targeting at Bcl-2 increases cytarabine-induced apoptosis in Raji cells

Acta Biochimica et Biophysica Sinica

Volumn 41, Issue 2, 2009, Pages 131-136

  He, Dongmei ^a   Fang, Baoying ^a  

^a MEDICAL COLLEGE OF JINAN UNIVERSITY   (China)

Author keywords

apoptosis; Bcl 2; cytarabine; Raji cell; small hairpin RNA

Indexed keywords

ARA;

CYTARABINE; MESSENGER RNA; PRIMER DNA; RNA; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; DRUG EFFECT; DRUG RESISTANCE; GENETIC TRANSFECTION; GENETICS; HUMAN; METABOLISM; NUCLEOTIDE SEQUENCE; PROTO ONCOGENE; RNA INTERFERENCE; TUMOR CELL LINE;

APOPTOSIS; BASE SEQUENCE; CELL LINE, TUMOR; CYTARABINE; DNA PRIMERS; DRUG RESISTANCE, NEOPLASM; GENES, BCL-2; HUMANS; RNA INTERFERENCE; RNA, MESSENGER; RNA, NEOPLASM; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 64249158406     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmn015     Document Type: Article

References (20)

1. Hammond SM, Bernstein E, Beach D and Harmon GJ. An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells. Nature 2000, 404: 293-296.
2. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K and Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001, 411: 494-498.
3. Nykanen A, Haley B and Zamore PD. ATP requirements and small interfering RNA structure in the RNA interference pathway. Cell 2001, 107:309-321.
4. Klasa RJ, Gillum AM, Klem RE and Frankel SR. Oblimersen Bcl-2 antisense: facilitating apoptosis in anticancer treatment. Antisense Nucleic Acid Drug Dev 2002, 12: 193-213.
5. O'Neill J, Manion M, Schwartz P and Hockenbery DM. Promises and challenges of targeting Bcl-2 anti-apoptotic proteins for cancer therapy. Biochim Biophys Acta 2004, 1705: 43-51.
6. Yu JY, DeRuiter SL and Turner DL. RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells. Proc Natl Acad Sci USA 2002, 99: 6047-6052.
7. -/- renal cancer. Cancer Res 2005, 65: 5221-5230.
8. Pan D, Wei L, Yao M, Wan D and Gu J. Down-regulation of CT120A by RNA interference suppresses lung cancer cells growth and sensitizes to ultraviolet-induced apoptosis. Cancer Lett 2006, 235: 26-33.
9. Hu HY and Zhang Y. siRNA inhibited Bcl-2 expression in human lung cancer cell lines. Academic Journal of Second Military Medical University 2005, 25: 483-486.
10. He DM, Zhang Y, Liu GX and Zou FY. Construction of Bcl-2 shRNA expression plasmid and its inhibition on the growth of HL-60 cells. Chin J Mod Med 2005, 15: 3736-3742.
11. Huang Y, Peng K, Su J, Huang Y, Xu Y and Wang S. Different effects of homocysteine and oxidized low density lipoprotein on methylation status in the promoter region of the estrogen receptor alpha gene. Acta Biochim Biophys Sin 2007, 39: 19-26.
12. Waters JS, Webb A, Cunningham D, Clarke PA, Raynaud F, di Stefano F and Cotter FE. Phase I clinical and pharmacokinetic study of Bcl-2 antisense oligonucleotide therapy in patients with non-Hodgkin's lymphoma. J Clin Oncol 2000, 18: 1812-1823.
13. van de Donk NW, Kamphuis MM, van Dijk M, Borst HP, Bloem AC and Lokhorst HM. Chemosensitization of myeloma plasma cells by an antisense-mediated downregulation of Bcl-2 protein. Leukemia 2003, 17: 211-219.
14. Tolcher AW, Chi K, Kuhn J, Gleave M, Patnaik A, Takimoto C and Schwartz G, et at. A phase II, pharmacokinetic, and biological correlative study of oblimersen sodium and docetaxel in patients with hormone-refractory prostate cancer. Clin Cancer Res 2005, 11: 3854-3861.
15. He DM and Zhang H. The studies of bcl-2 antisense oligodeoxynucleotide increasing the sensitivity of NCI-H460 to docetaxel and radiation. 10 Academic Journal of Second Military Medical University 2005, 26: 476-479.
16. Hao JH, Cm QL, Liu BY, Li IF, Chen XH, Ji YB and Zhu ZG, et al. Inhibition of the proliferation of human gastric cancer cells SGC-7901 in vitro and in vivo using Bcl-2 siRNA. Chin Med J (Engl) 2007, 120: 2105-2111.
17. Ocker M, Neureiter D, Lueders M, Zopf S, Ganslmayer M, Hahn EG and Herold C, et al. Variants of bcl-2 specific siRNA for silencing antiapoptotic Bcl-2 in pancreatic cancer. Gut 2005, 54: 1298-1308.
18. Nagamatsu K, Tsuchiya F, Oguma K, Marayaraa H, Kano R and Hasegawa A. The effect of small interfering RNA (siRNA) against the Bcl-2 gene on apoptosis and chemosensitivity in a canine mammary gland tumor cell line. Res Vet Sci 2008, 84: 49-55.
19. Lei XY, Zhong M, Feng LF, Zhu BY, Tang SS and Liao DF. siRNA-mediated Bcl-2 and Bcl-xl gene silencing sensitizes human hepatoblastoma cells to chemotherapeutic drugs. Clin Exp Pharmacol Physiol 2007, 34: 450-456.
20. Ramanarayanan J, Hernandez-Ilizaliturri FJ, Chanan-Khan A and Czuczman MS. Pro-apoptotic therapy with the oligonucleotide Genasense (oblimersen sodium) targeting Bcl-2 protein expression enhances the biological anti-tumour activity of rituximab. Br J Haematol 2004, 127: 519-30.